🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsStructure-activity relationships of GLP-1 analogs — anyone have experience? Page 3

Structure-activity relationships of GLP-1 analogs — anyone have experience?

sarah_TO Wed, Oct 30, 2024 at 10:31 PM 32 replies 1,968 viewsPage 3 of 7
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Oct 31, 2024 at 2:46 AM#11
NurseKim_ATL said:
Structure-activity relationships of is not that straightforward in my experience

This is exactly right. NurseKim_ATL articulated what I have been trying to explain to my doctor for months. The Structure-activity aspect is the most important factor.

7 7pete_nash, hank_denver, carlos_SATX and 4 others
Reply Quote Save Share Report
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Oct 31, 2024 at 3:03 AM#12

Reading this thread on Structure-activity hits close to home. Night shift nurse — I started at 263 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 38 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Structure-activity — take the leap. It was the best health decision I have ever made. ❤️

11 22julia.endo, JessicaM_2024, TomFromTexas and 8 others
Reply Quote Save Share Report
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Oct 31, 2024 at 3:20 AM#13

KevinCompounds — that is really helpful context on Structure-activity. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

41 7KetoKyle, CanadaChris, ZaraB_AL and 38 others
Reply Quote Save Share Report
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Oct 31, 2024 at 3:37 AM#14

To answer MeganSA_TX's question specifically:

From a clinical standpoint, Structure-activity is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

47 24chris_chi24, tampaLisa73, KarenAZ_mom and 44 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Oct 31, 2024 at 3:54 AM#15

Bookmarked 📌 The Structure-activity info in this thread is essential. Coming back to this for sure.

5 9SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 2 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register